|
PJA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.301200000554E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71519999980774E-07 |
| Normal-vs-Stage2 |
7.54700000000774E-05 |
| Normal-vs-Stage3 |
7.530200E-02 |
| Normal-vs-Stage4 |
6.26489999999702E-05 |
| Stage1-vs-Stage2 |
6.360200E-01 |
| Stage1-vs-Stage3 |
7.395600E-02 |
| Stage1-vs-Stage4 |
3.867000E-01 |
| Stage2-vs-Stage3 |
1.176430E-01 |
| Stage2-vs-Stage4 |
6.280000E-01 |
| Stage3-vs-Stage4 |
1.016950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69399999974773E-07 |
| Normal-vs-AfricanAmerican |
4.01110000000093E-05 |
| Normal-vs-Asian |
1.199530E-02 |
| Caucasian-vs-AfricanAmerican |
7.840600E-01 |
| Caucasian-vs-Asian |
9.350800E-01 |
| AfricanAmerican-vs-Asian |
8.604400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4791999847219E-09 |
| Normal-vs-Female |
1.396360E-01 |
| Male-vs-Female |
2.57900000000255E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.98859999999935E-05 |
| Normal-vs-Extreme_Weight |
5.95160000171902E-08 |
| Normal-vs-Obese |
1.203310E-04 |
| Normal-vs-Extreme_Obese |
2.151000E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.148800E-01 |
| Normal_Weight-vs-Obese |
4.356800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.870000E-01 |
| Extreme_Weight-vs-Obese |
1.196240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.411400E-01 |
| Obese-vs-Extreme_Obese |
2.583000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.382320E-02 |
| Normal-vs-Age(41-60Yrs) |
2.36259999999433E-05 |
| Normal-vs-Age(61-80Yrs) |
3.1300000002954E-07 |
| Normal-vs-Age(81-100Yrs) |
1.580720E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.602000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.925810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.753150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.538250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.042200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.734400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.57739999950834E-07 |
| Normal-VS-Type2 PRCC |
5.50799999999851E-05 |
| Normal-VS-KIRP CIMP |
1.507620E-02 |
| Normal-VS-Unclassified PRCC |
2.482300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.659800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.241000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.484410E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.167400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.134400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.855400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13130000001238E-06 |
| Normal-vs-N1 |
1.926340E-02 |
| Normal-vs-N2 |
1.303680E-02 |
| N0-vs-N1 |
2.267400E-01 |
| N0-vs-N2 |
9.826600E-01 |
| N1-vs-N2 |
5.825000E-01 |
|
|
